COVID-19 Vaccine Shipped, and Drug Trials Start
Share
[aggregation-styles]
TIME
Moderna Therapeutics, a biotech company based in Cambridge, Mass., has shipped the first batches of its COVID-19 vaccine. The vaccine was created just 42 days after the genetic sequence of the COVID-19 virus, called SARS-CoV-2, was released by Chinese researchers in mid-January.
The first vials were sent to the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) in Bethesda, MD, which will ready the vaccine for human testing as early as April.
NIH scientists also began testing an antiviral drug called remdesivir that had been developed for Ebola, on a patient infected with SARS-CoV-2. The trial is the first to test a drug for treating COVID-19, and will be led by a team at the University of Nebraska Medical Center.
The first patient to volunteer for the ground-breaking study is a passenger who was brought back to the US after testing positive for the disease aboard the Diamond Princess. Others diagnosed with COVID-19 who have been hospitalized will also be part of the study.
Remdesivir showed encouraging results among animals infected with two related coronaviruses, one responsible for severe acute respiratory syndrome (SARS) and another for causing Middle East respiratory syndrome (MERS).
Read More →
TIME
Moderna Therapeutics, a biotech company based in Cambridge, Mass., has shipped the first batches of its COVID-19 vaccine. The vaccine was created just 42 days after the genetic sequence of the COVID-19 virus, called SARS-CoV-2, was released by Chinese researchers in mid-January.
The first vials were sent to the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) in Bethesda, MD, which will ready the vaccine for human testing as early as April.
NIH scientists also began testing an antiviral drug called remdesivir that had been developed for Ebola, on a patient infected with SARS-CoV-2. The trial is the first to test a drug for treating COVID-19, and will be led by a team at the University of Nebraska Medical Center.
The first patient to volunteer for the ground-breaking study is a passenger who was brought back to the US after testing positive for the disease aboard the Diamond Princess. Others diagnosed with COVID-19 who have been hospitalized will also be part of the study.
Remdesivir showed encouraging results among animals infected with two related coronaviruses, one responsible for severe acute respiratory syndrome (SARS) and another for causing Middle East respiratory syndrome (MERS).
Read More →
By Alice Park | 25 Feb 2020
RELATED TOPICS:
Trump Says He Will Order Voter ID Requirement for Every Vote
Politics /
16 hours ago
Greta Thunberg Joins Flotilla Heading for Gaza With Aid
World /
16 hours ago
Chicago Mayor Says Police Will Not Aid Federal Troops or Agents
U.S. /
16 hours ago
Post-War Gaza Plan Sees Relocation of Population, ‘Digital Token’ for Palestinian Land: Washington Post
World /
16 hours ago
Labor Day Quiz: Do You Know What a Knocker-Upper Is?
Opinion /
17 hours ago
Judge Blocks Pillar of Trump’s Mass Deportation Campaign
Latest /
2 days ago
Visalia Driver Arrested for DUI After Multiple Crashes and Pedestrian Injured
Crime /
2 days ago
Fresno County Garnet Fire Grows to 18,748 Acres in Sierra National Forest
A lightning-sparked wildfire, the Garnet Fire, in the Sierra National Forest has burned 18,748 acres in Fresno County and remains at 8% cont...
Local /
16 hours ago
Categories
Latest
Videos

Local /
16 hours ago
Fresno County Garnet Fire Grows to 18,748 Acres in Sierra National Forest

World /
16 hours ago
Israel Pounds Gaza City Suburbs, Netanyahu to Convene Security Cabinet

Politics /
16 hours ago
Trump Says He Will Order Voter ID Requirement for Every Vote

World /
16 hours ago
Greta Thunberg Joins Flotilla Heading for Gaza With Aid

U.S. /
16 hours ago
Chicago Mayor Says Police Will Not Aid Federal Troops or Agents

World /
16 hours ago
Post-War Gaza Plan Sees Relocation of Population, ‘Digital Token’ for Palestinian Land: Washington Post

Video /
2 days ago